A randomized, open label, multicenter, phase 3, 2-arm study of androgen deprivation with leuprolide (L), ± docetaxel (D) for clinically asymptomatic prostate cancer (PC) subjects with a rising PSA ...
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (Bicycle™) product platform ...
Patients with HER2-positive metastatic breast cancer treated with the novel antibody drug conjugate ARX788 conferred a significant survival benefit compared with those treated with a control. Patients ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback